Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 8730-8731 [2019-04404]

Download as PDF 8730 Federal Register / Vol. 84, No. 47 / Monday, March 11, 2019 / Notices have been updated to reflect the Department’s 2019 poverty guidelines as published in 84 FR 1167 (February 1, 2019). LOW-INCOME LEVELS BASED ON THE 2019 POVERTY GUIDELINES FOR THE 48 CONTIGUOUS STATES AND THE DISTRICT OF COLUMBIA Persons in family/household * 1 2 3 4 5 6 7 8 Puerto Rico or other outlying jurisdictions. Puerto Rico and other outlying jurisdictions shall use income guidelines for the 48 Contiguous States and the District of Columbia. Dated: March 4, 2019. George Sigounas, Administrator. [FR Doc. 2019–04407 Filed 3–8–19; 8:45 am] BILLING CODE 4165–15–P Income Level ** ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... $24,980 33,820 42,660 51,500 60,340 69,180 78,020 86,860 For families with more than 8 persons, add $8,840 for each additional person. DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Presidential Advisory Council on Combating AntibioticResistant Bacteria Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health. ACTION: Notice. AGENCY: LOW-INCOME LEVELS BASED ON THE 2019 POVERTY GUIDELINES FOR SUMMARY: As stipulated by the Federal ALASKA Advisory Committee Act, the Persons in family/household * 1 2 3 4 5 6 7 8 Income Level ** ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... $31,200 42,260 53,320 64,380 75,440 86,500 97,560 108,620 For families with more than 8 persons, add $11,060 for each additional person. LOW-INCOME LEVELS BASED ON THE 2019 POVERTY GUIDELINES FOR HAWAII Persons in family/household * 1 2 3 4 5 6 7 8 Income Level ** ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... ...................................... $28,760 38,920 49,080 59,240 69,400 79,560 89,720 99,880 amozie on DSK9F9SC42PROD with NOTICES For families with more than 8 persons, add $10,160 for each additional person. * Includes only dependents listed on federal income tax forms. ** Adjusted gross income for calendar year 2018. Separate poverty guidelines figures for Alaska and Hawaii reflect Office of Economic Opportunity administrative practice beginning in the 1966–1970 period since the U.S. Census Bureau poverty thresholds do not have separate figures for Alaska and Hawaii. The poverty guidelines are not defined for VerDate Sep<11>2014 18:41 Mar 08, 2019 Jkt 247001 Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held on April 8, 2019, for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). The meeting will be open to the public via teleconference. Preregistration is required for members of the public who wish to attend the meeting via teleconference. Individuals who wish to send in their public comments should send an email to CARB@hhs.gov. Registration information is available on the website https://www.hhs.gov/ash/carb/ and must be completed by April 2, 2019. Additional information about registering for the meeting and providing public comments can be obtained at https:// www.hhs.gov/ash/carb/ on the Meetings page. DATES: The meeting is scheduled to be held on April 8, 2019, from 12:00 p.m. to 2:00 p.m. ET (times are tentative and subject to change). The confirmed times and agenda items for the meeting will be posted on the website for the Advisory Council at https://www.hhs.gov/ash/ carb/ when this information becomes available. Pre-registration for attending the meeting is required to be completed no later than April 2, 2019. ADDRESSES: Instructions regarding attending this meeting virtually will be posted one week prior to the meeting at: https://www.hhs.gov/ash/carb/. FOR FURTHER INFORMATION CONTACT: Jomana Musmar, Designated Federal Officer, Presidential Advisory Council on Combating Antibiotic-Resistant PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, Room L133, Switzer Building, 330 C. St. SW, Washington, DC 20201. Phone: (202) 690–5566; email: CARB@hhs.gov. SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 18, 2014, authority was given to the Secretary of HHS to establish the Advisory Council, in consultation with the Secretaries of Defense and Agriculture. Activities of the Advisory Council are governed by the provisions of Public Law 92–463, as amended (5 U.S.C. App.), which sets forth standards for the formation and use of federal advisory committees. The Advisory Council will provide advice, information, and recommendations to the Secretary of HHS regarding programs and policies intended to support and evaluate the implementation of Executive Order 13676, including the National Strategy for Combating Antibiotic-Resistant Bacteria and the National Action Plan for Combating Antibiotic-Resistant Bacteria. The Advisory Council shall function solely for advisory purposes. In carrying out its mission, the Advisory Council will provide advice, information, and recommendations to the Secretary regarding programs and policies intended to preserve the effectiveness of antibiotics by optimizing their use; advance research to develop improved methods for combating antibiotic resistance and conducting antibiotic stewardship; strengthen surveillance of antibioticresistant bacterial infections; prevent the transmission of antibiotic-resistant bacterial infections; advance the development of rapid point-of-care and agricultural diagnostics; further research on new treatments for bacterial infections; develop alternatives to antibiotics for agricultural purposes; maximize the dissemination of up-todate information on the appropriate and proper use of antibiotics to the general public and human and animal healthcare providers; and improve international coordination of efforts to combat antibiotic resistance. The public meeting will be dedicated to deliberation and vote of the report with recommendation from the Immediate Action Subcommittee of the Advisory Council. The meeting agenda will be posted on the Advisory Council website at https://www.hhs.gov/ash/ carb/ when it has been finalized. All agenda items are tentative and subject to change. Instructions regarding attending this meeting virtually will be posted one E:\FR\FM\11MRN1.SGM 11MRN1 8731 Federal Register / Vol. 84, No. 47 / Monday, March 11, 2019 / Notices week prior to the meeting at: https:// www.hhs.gov/ash/carb/. Members of the public will have the opportunity to provide comments prior to the Advisory Council meeting by emailing CARB@hhs.gov. Public comments should be sent in by midnight April 2, 2019, and should be limited to no more than one page. All public comments received prior to April 2, 2019, will be provided to Advisory Council members and will be acknowledged during the public teleconference. Dated: February 26, 2019. Jomana F. Musmar, Designated Federal Officer, Presidential Advisory Council on Combating AntibioticResistant Bacteria, Committee Manager. [FR Doc. 2019–04404 Filed 3–8–19; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [Document Identifier 4040–0002] Agency Information Collection Request. 60-Day Public Comment Request AGENCY: Office of the Secretary, HHS. ACTION: Notice. In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. DATES: Comments on the ICR must be received on or before May 10, 2019. ADDRESSES: Submit your comments to Sherrette.Funn@hhs.gov or by calling (202) 795–7714. FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting information, please include the document identifier 4040–0002–60D and project title for reference., to Sherrette.funn@hhs.gov, or call the Reports Clearance Officer. SUPPLEMENTARY INFORMATION: Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to SUMMARY: enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Title of the Collection: The SF–424 Mandatory Form. Type of Collection: Reinstatement without change. OMB No. 4040–0002. Abstract: The SF–424 Mandatory Form provides the Federal grant-making agencies an alternative to the Standard Form 424 data set and form. Agencies may use the SF–424 Mandatory Form for grant programs not required to collect all the data that is required on the SF–424 core data set and form. Type of respondent: The SF–424 Mandatory form is used by organizations to apply for Federal financial assistance in the form of grants. These forms are submitted to the Federal grant-making agencies for evaluation and review. ANNUALIZED BURDEN HOUR TABLE SF–424 Mandatory ........................... Grant applicants ............................... 5761 1 1 5761 Total ........................................... ........................................................... 5761 1 1 5761 Tissue Safety and Availability (ACBTSA) will hold a meeting. The meeting will be open to the public. BILLING CODE 4151–AE–P The meeting will take place Monday, April 15, 2019, from 8:00 a.m.– 4:30 p.m. and Tuesday, April 16, 2019, from 8:30 a.m.–4:00 p.m. DEPARTMENT OF HEALTH AND HUMAN SERVICES ADDRESSES: DATES: [FR Doc. 2019–04288 Filed 3–8–19; 8:45 am] Meeting of the Advisory Committee on Blood and Tissue Safety and Availability Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health. ACTION: Notice. AGENCY: amozie on DSK9F9SC42PROD with NOTICES Average burden per response Respondents (if necessary) Dated: March 5, 2019. Terry Clark, Assistant Information Collection Clearance Officer. Number of respondents Number of responses per respondents Forms As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the Advisory Committee on Blood and SUMMARY: VerDate Sep<11>2014 18:41 Mar 08, 2019 Jkt 247001 U.S. Department of Health & Human Services, Hubert H. Humphrey Building, (Conference Room 800), 200 Independence Ave. SW, Washington, DC 20201. Mr. James Berger, Designated Federal Officer for the ACBTSA, Senior Advisor for Blood and Tissue Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services, Mary E. Switzer Building, 330 C Street SW, Suite L100, Washington, DC 20024. Phone: (202) 795–7697; Fax: (202) 691–2102; Email: ACBTSA@ hhs.gov. FOR FURTHER INFORMATION CONTACT: PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 Total burden hours The ACBTSA provides advice to the Secretary through the Assistant Secretary for Health. The Committee advises on a range of policy issues to include: (1) Identification of public health issues through surveillance of blood and tissue safety issues with national survey and data tools; (2) identification of public health issues that affect availability of blood, blood products, and tissues; (3) broad public health, ethical, and legal issues related to the safety of blood, blood products, and tissues; (4) the impact of various economic factors (e.g., product cost and supply) on safety and availability of blood, blood products, and tissues; (5) risk communications related to blood transfusion and tissue transplantation; and (6) identification of infectious disease transmission issues for blood, organs, blood stem cells and tissues. The Committee has met regularly since its establishment in 1997. SUPPLEMENTARY INFORMATION: E:\FR\FM\11MRN1.SGM 11MRN1

Agencies

[Federal Register Volume 84, Number 47 (Monday, March 11, 2019)]
[Notices]
[Pages 8730-8731]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04404]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of the Assistant Secretary for Health.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held on April 8, 2019, for the 
Presidential Advisory Council on Combating Antibiotic-Resistant 
Bacteria (Advisory Council). The meeting will be open to the public via 
teleconference. Pre-registration is required for members of the public 
who wish to attend the meeting via teleconference. Individuals who wish 
to send in their public comments should send an email to CARB@hhs.gov. 
Registration information is available on the website https://www.hhs.gov/ash/carb/ and must be completed by April 2, 2019. 
Additional information about registering for the meeting and providing 
public comments can be obtained at https://www.hhs.gov/ash/carb/ on the 
Meetings page.

DATES: The meeting is scheduled to be held on April 8, 2019, from 12:00 
p.m. to 2:00 p.m. ET (times are tentative and subject to change). The 
confirmed times and agenda items for the meeting will be posted on the 
website for the Advisory Council at https://www.hhs.gov/ash/carb/ when 
this information becomes available. Pre-registration for attending the 
meeting is required to be completed no later than April 2, 2019.

ADDRESSES: Instructions regarding attending this meeting virtually will 
be posted one week prior to the meeting at: https://www.hhs.gov/ash/carb/.

FOR FURTHER INFORMATION CONTACT: Jomana Musmar, Designated Federal 
Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, Room L133, Switzer Building, 
330 C. St. SW, Washington, DC 20201. Phone: (202) 690-5566; email: 
CARB@hhs.gov.

SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 
18, 2014, authority was given to the Secretary of HHS to establish the 
Advisory Council, in consultation with the Secretaries of Defense and 
Agriculture. Activities of the Advisory Council are governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets 
forth standards for the formation and use of federal advisory 
committees.
    The Advisory Council will provide advice, information, and 
recommendations to the Secretary of HHS regarding programs and policies 
intended to support and evaluate the implementation of Executive Order 
13676, including the National Strategy for Combating Antibiotic-
Resistant Bacteria and the National Action Plan for Combating 
Antibiotic-Resistant Bacteria. The Advisory Council shall function 
solely for advisory purposes.
    In carrying out its mission, the Advisory Council will provide 
advice, information, and recommendations to the Secretary regarding 
programs and policies intended to preserve the effectiveness of 
antibiotics by optimizing their use; advance research to develop 
improved methods for combating antibiotic resistance and conducting 
antibiotic stewardship; strengthen surveillance of antibiotic-resistant 
bacterial infections; prevent the transmission of antibiotic-resistant 
bacterial infections; advance the development of rapid point-of-care 
and agricultural diagnostics; further research on new treatments for 
bacterial infections; develop alternatives to antibiotics for 
agricultural purposes; maximize the dissemination of up-to-date 
information on the appropriate and proper use of antibiotics to the 
general public and human and animal healthcare providers; and improve 
international coordination of efforts to combat antibiotic resistance.
    The public meeting will be dedicated to deliberation and vote of 
the report with recommendation from the Immediate Action Subcommittee 
of the Advisory Council. The meeting agenda will be posted on the 
Advisory Council website at https://www.hhs.gov/ash/carb/ when it has 
been finalized. All agenda items are tentative and subject to change.
    Instructions regarding attending this meeting virtually will be 
posted one

[[Page 8731]]

week prior to the meeting at: https://www.hhs.gov/ash/carb/.
    Members of the public will have the opportunity to provide comments 
prior to the Advisory Council meeting by emailing CARB@hhs.gov. Public 
comments should be sent in by midnight April 2, 2019, and should be 
limited to no more than one page. All public comments received prior to 
April 2, 2019, will be provided to Advisory Council members and will be 
acknowledged during the public teleconference.

    Dated: February 26, 2019.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria, Committee Manager.
[FR Doc. 2019-04404 Filed 3-8-19; 8:45 am]
 BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.